Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Population Pharmacokinetic-Pharmacodynamic Modeling of Neutrophil and Platelet Count for Lower-Intensity Therapy of CPX-351 Combined with Venetoclax in Acute Myeloid Leukemia

Yali Liang, Sarah F Cook, Ronald Cheung, Honghui Zhou, Sheryl Coppola, Qi Wang, Donald E Mager, Scott A Van Wart

Blood (2023) 142 (Supplement 1): 2902.

https://doi.org/10.1182/blood-2023-182111

Published: 2023

Journal Articles

Platelet Transfusions Can Increase or Decrease the Inflammatory Response and Mortality in a Murine Model of Neonatal Polymicrobial Sepsis

Patricia E Davenport, Hsuan-Hao Fan, Emily Nolton, Henry Feldman, Viola Lorenz, Jorge Canas, Maikel Acosta-Zaldivar, William Yakah, Sean R Stowell, Julia Koehler, Camilia Martin, Donald E Mager, Martha Sola-Visner

Blood (2021) 138 (Supplement 1): 2147.

https://doi.org/10.1182/blood-2021-146582

Published: 2021

Journal Articles

Population Pharmacokinetic (PK)/Pharmacodynamic (PD) Modeling of Myelosuppression in Patients with Hematologic Malignancies for CPX-351 and Standard-of-Care 7+3 Therapy

Qi Wang, PhD, Sarah F. Cook, Scott A. Van Wart, Donald E. Mager, Stefan Faderl, MD

Blood (2018) 132 (Supplement 1): 4037.

https://doi.org/10.1182/blood-2018-99-111918

Published: 2018

Journal Articles

Greater Efficacy and Potency of Obinutuzumab Compared with Rituximab in Chronic Lymphocytic Leukemia Patients Confirmed By a Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Model

Kubra Kamisoglu, Alex Phipps, Candice Jamois, Vincent Buchheit, Georgina Meneses-Lorente, Günter Fingerle-Rowson, Jonathan Wagg, Donald E Mager

Blood (2017) 130 (Supplement 1): 1267.

https://doi.org/10.1182/blood.V130.Suppl_1.1267.1267

Published: 2017

Journal Articles

Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan

Zhi-Jian Liu, Karin M. Hoffmeister, Zhongbo Hu, Donald E. Mager, Sihem Ait-Oudhia, Marlyse A. Debrincat, Irina Pleines, Emma C. Josefsson, Benjamin T. Kile, Joseph Italiano, Jr, Haley Ramsey, Renata Grozovsky, Peter Veng-Pedersen, Chaitanya Chavda, Martha Sola-Visner

Blood (2014) 123 (22): 3381–3389.

https://doi.org/10.1182/blood-2013-06-508200

Published: 2014

Includes: Supplemental data

NARROW

Population Pharmacokinetic-Pharmacodynamic Modeling of Neutrophil and Platelet Count for Lower-Intensity Therapy of CPX-351 Combined with Venetoclax in Acute Myeloid Leukemia

Platelet Transfusions Can Increase or Decrease the Inflammatory Response and Mortality in a Murine Model of Neonatal Polymicrobial Sepsis

Population Pharmacokinetic (PK)/Pharmacodynamic (PD) Modeling of Myelosuppression in Patients with Hematologic Malignancies for CPX-351 and Standard-of-Care 7+3 Therapy

Greater Efficacy and Potency of Obinutuzumab Compared with Rituximab in Chronic Lymphocytic Leukemia Patients Confirmed By a Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Model

Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan

Email alerts

ASH Publications

American Society of Hematology

Population Pharmacokinetic-Pharmacodynamic Modeling of Neutrophil and Platelet Count for Lower-Intensity Therapy of CPX-351 Combined with Venetoclax in Acute Myeloid Leukemia

Platelet Transfusions Can Increase or Decrease the Inflammatory Response and Mortality in a Murine Model of Neonatal Polymicrobial Sepsis

Population Pharmacokinetic (PK)/Pharmacodynamic (PD) Modeling of Myelosuppression in Patients with Hematologic Malignancies for CPX-351 and Standard-of-Care 7+3 Therapy

Greater Efficacy and Potency of Obinutuzumab Compared with Rituximab in Chronic Lymphocytic Leukemia Patients Confirmed By a Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Model

Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only